Ping Liao

590 total citations
24 papers, 424 citations indexed

About

Ping Liao is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ping Liao has authored 24 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Immunology. Recurrent topics in Ping Liao's work include Cancer Immunotherapy and Biomarkers (5 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers) and Immune Cell Function and Interaction (3 papers). Ping Liao is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers) and Immune Cell Function and Interaction (3 papers). Ping Liao collaborates with scholars based in China, Macao and United States. Ping Liao's co-authors include Guibo Sun, Xiaobo Sun, Howard L. McLeod, Yijing He, Xin Chen, Jie Jian, Yun Luo, Ke Yang, Md Sahidul Islam and Chan Zhang and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Molecules.

In The Last Decade

Ping Liao

23 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping Liao China 13 200 87 80 73 71 24 424
Mi‐Hyoung Kim South Korea 12 302 1.5× 61 0.7× 80 1.0× 113 1.5× 98 1.4× 15 574
Dazhi Sun China 12 127 0.6× 60 0.7× 141 1.8× 32 0.4× 74 1.0× 24 430
Lian Gong China 12 194 1.0× 60 0.7× 67 0.8× 45 0.6× 80 1.1× 19 394
Yingchun Zhang China 14 171 0.9× 47 0.5× 82 1.0× 50 0.7× 46 0.6× 44 467
Wanfu Lin China 12 175 0.9× 109 1.3× 67 0.8× 62 0.8× 24 0.3× 24 403
Qingchun Diao China 13 159 0.8× 40 0.5× 54 0.7× 66 0.9× 35 0.5× 37 436
Mitsuya Ito Japan 11 146 0.7× 88 1.0× 80 1.0× 31 0.4× 70 1.0× 37 450
Rongmu Xia China 10 279 1.4× 107 1.2× 56 0.7× 27 0.4× 26 0.4× 14 405
Fujing Wang China 11 165 0.8× 41 0.5× 54 0.7× 32 0.4× 52 0.7× 24 381

Countries citing papers authored by Ping Liao

Since Specialization
Citations

This map shows the geographic impact of Ping Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Liao more than expected).

Fields of papers citing papers by Ping Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Liao. The network helps show where Ping Liao may publish in the future.

Co-authorship network of co-authors of Ping Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Liao. A scholar is included among the top collaborators of Ping Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Liao. Ping Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yibo, Mengmeng Jiang, Ping Liao, et al.. (2025). miR-125b-5p sensitizes colorectal cancer to anti-PD-L1 therapy by decreasing TNFR2 expression on tumor cells. Journal of Leukocyte Biology. 117(6).
2.
Han, Chenxia, Zhenlu Li, Ping Liao, et al.. (2025). TRPV6-mediated Store-operated Ca2+ Entry Participates in Pancreatic Acinar Cell Injury During Acute Pancreatitis. Cellular and Molecular Gastroenterology and Hepatology. 19(12). 101620–101620. 1 indexed citations
3.
Chen, Xin, Ping Liao, Fengzai Tang, et al.. (2025). 540Gbps IMDD Transmission over 30km SMF using 110GHz Bandwidth InP EML. Th4B.2–Th4B.2. 1 indexed citations
4.
Liao, Ping, Mengmeng Jiang, Md Sahidul Islam, Yiru Wang, & Xin Chen. (2023). TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments. Frontiers in Immunology. 14. 1097090–1097090. 10 indexed citations
5.
Li, Wei, Chengfang Zhou, Ping Liao, et al.. (2022). Dissecting the role of cell signaling versus CD8+ T cell modulation in propranolol antitumor activity. Journal of Molecular Medicine. 100(9). 1299–1306. 11 indexed citations
6.
Chen, Shaokui, Ping Liao, Long Fu Xi, et al.. (2022). The therapeutic effect of tacrolimus in a mouse psoriatic model is associated with the induction of myeloid-derived suppressor cells. PubMed. 3(4). 190–197. 3 indexed citations
7.
Chen, Shaokui, Ruixin Li, Yibo Chen, et al.. (2022). Scutellarin enhances anti-tumor immune responses by reducing TNFR2-expressing CD4+Foxp3+ regulatory T cells. Biomedicine & Pharmacotherapy. 151. 113187–113187. 16 indexed citations
8.
Chen, Shaokui, Zibei Lin, Md Sahidul Islam, et al.. (2022). Topical Application of Tetrandrine Nanoemulsion Promotes the Expansion of CD4+Foxp3+ Regulatory T Cells and Alleviates Imiquimod-Induced Psoriasis in Mice. Frontiers in Immunology. 13. 800283–800283. 13 indexed citations
9.
Jiang, Mengmeng, Yang Yang, Liling Niu, et al.. (2022). MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2. Journal for ImmunoTherapy of Cancer. 10(11). e005241–e005241. 23 indexed citations
10.
Chen, Zhonghao, Ying Zhang, Meng Wang, et al.. (2022). Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review. International Journal of Biological Sciences. 18(12). 4629–4641. 27 indexed citations
11.
Liao, Ping, Kun Song, Zhaoqian Liu, et al.. (2020). Propranolol Suppresses the Growth of Colorectal Cancer Through Simultaneously Activating Autologous CD8+ T Cells and Inhibiting Tumor AKT/MAPK Pathway. Clinical Pharmacology & Therapeutics. 108(3). 606–615. 33 indexed citations
12.
Li, Wei, Weili Wang, Ping Liao, et al.. (2020). High levels of Tumor-Infiltrating Lymphocytes showed Better Clinical outcomes in FOLFOX-treated Gastric Cancer Patients. Pharmacogenomics. 21(11). 751–759. 2 indexed citations
13.
Zhang, Chan, et al.. (2019). Epigallocatechin gallate prevents mitochondrial impairment and cell apoptosis by regulating miR-30a/p53 axis. Phytomedicine. 61. 152845–152845. 41 indexed citations
14.
15.
Liao, Ping, Wěi Li, Jamie K. Teer, et al.. (2018). Genome-scale analysis identifies SERPINE1 and SPARC as diagnostic and prognostic biomarkers in gastric cancer. OncoTargets and Therapy. Volume 11. 6969–6980. 48 indexed citations
16.
Wang, Weili, Kuansong Wang, Zihua Chen, et al.. (2018). Immunoclassification characterized by CD8 and PD-L1 expression is associated with the clinical outcome of gastric cancer patients. Oncotarget. 9(15). 12164–12173. 21 indexed citations
17.
Wang, Min, Guibo Sun, Yuyang Du, et al.. (2017). Myricitrin Protects Cardiomyocytes from Hypoxia/Reoxygenation Injury: Involvement of Heat Shock Protein 90. Frontiers in Pharmacology. 8. 353–353. 36 indexed citations
18.
Yang, Ke, Hai‐Jing Zhang, Yun Luo, et al.. (2017). Gypenoside XVII Prevents Atherosclerosis by Attenuating Endothelial Apoptosis and Oxidative Stress: Insight into the ERα-Mediated PI3K/Akt Pathway. International Journal of Molecular Sciences. 18(2). 77–77. 63 indexed citations
19.
Zhong, Meizuo, Weili Wang, Ping Liao, et al.. (2017). EBV infection and MSI status significantly influence the clinical outcomes of gastric cancer patients. Clinica Chimica Acta. 471. 216–221. 17 indexed citations
20.
Liao, Ping, Guibo Sun, Chan Zhang, et al.. (2016). Bauhinia championii Flavone Attenuates Hypoxia-Reoxygenation Induced Apoptosis in H9c2 Cardiomyocytes by Improving Mitochondrial Dysfunction. Molecules. 21(11). 1469–1469. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026